Palbociclib Hydrochloride-impurities | Pharmaffiliates

Palbociclib Hydrochloride

Palbociclib Hydrochloride, sold under the brand name Ibrance among others, is a medication developed by Pfizer for the treatment of HR-positive and HER2-negative breast cancer. Reference standards of Palbociclib Hydrochloride API, and its pharmacopeial, non pharmacopeial impurities, and stable isotopes are listed below.

PA 16 3010000

Palbociclib Hydrochloride - API


  • Catalogue No.:PA 16 3010000

  • CAS :

    827022-32-2

  • Molecular Formula : C24H30ClN7O2

  • Molecular Weight : 484